Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR‐T cell infusion by Paulus A. F. Geerts, Nils ’t Hart, Otto Visser, Valentín Ortiz‐Maldonado, Martine E. D. Chamuleau

Get full text

Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG) by Igor Aurer, Martin Dreyling, Massimo Federico, Herve Tilly, Kim Linton, Eva Kimby, Martine E. D. Chamuleau, Marie Jose Kersten

Get full text

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice by Matias Mendeville, Margaretha G. M. Roemer, G. Tjitske Los-de Vries, Martine E. D. Chamuleau, Daphne de Jong, Bauke Ylstra

Get full text

Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome by Martine E.D. Chamuleau, Theresia M. Westers, Linda van Dreunen, Judith Groenland, Adri Zevenbergen, Corien M. Eeltink, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht

Get full text

Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015 by Avinash G. Dinmohamed, Djamila E. Issa, Marjolein W.M. van der Poel, Harry C. Schouten, Pieternella J. Lugtenburg, Martine E.D. Chamuleau, Sonja Zweegman, Otto Visser

Get full text

Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands by Elise R. A. Pennings, Müjde Durmaz, Otto Visser, Eduardus F. M. Posthuma, Djamila E. Issa, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed

Get full text

Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromes by Josephine D. Kahn, Martine E.D. Chamuleau, Theresa M. Westers, Peter M. Van de Ven, Linda van Dreunen, Margot van Spronsen, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht

Get full text

First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline by Karima Amaador, Marie José Kersten, Hein P. J. Visser, Laurens Nieuwenhuizen, Roelandt F. J. Schop, Martine E. D. Chamuleau, Gerjo A. Velders, Monique C. Minnema, Josephine Mathilde Iris Vos

Get full text

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome by Martine E.D. Chamuleau, Arjan A. van de Loosdrecht, Corine J. Hess, Jeroen J.W.M. Janssen, Adri Zevenbergen, Ruud Delwel, Peter J.M. Valk, Bob Löwenberg, Gert J. Ossenkoppele

Get full text

Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989–2010 by Djamila E. Issa, Saskia A.M. van de Schans, Martine E.D. Chamuleau, Henrike E. Karim-Kos, Marielle Wondergem, Peter C. Huijgens, Jan Willem W. Coebergh, Sonja Zweegman, Otto Visser

Get full text

Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses by Marvin M. van Luijn, Martine E.D. Chamuleau, James A. Thompson, Suzanne Ostrand-Rosenberg, Theresia M. Westers, Yuri Souwer, Gert J. Ossenkoppele, S. Marieke van Ham, Arjan A. van de Loosdrecht

Get full text

Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies by Hilma J. van der Horst, Simone C. Oostindie, Saskia. A. G. M. Cillessen, Anne T. Gelderloos, Marije B. Overdijk, Inger. S. Nijhof, Sonja Zweegman, Martine E. D. Chamuleau, Esther C. W. Breij, Tuna Mutis

Get full text

P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ATTENUATED R-CHOP by Diana Al-Sarayfi, Mirian Brink, Martine E. D. Chamuleau, Rolf Brouwer, Roos van Rijn, Djamila Issa, Wendy Deenik, Gerwin Huls, Rogier Mous, Joost S.P. Vermaat, Josee M. Zijlstra, Tom van Meerten, Marcel Nijland

Get full text

Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma by Carolien C. H. M. Maas, David van Klaveren, Müjde Durmaz, Otto Visser, Djamila E. Issa, Eduardus F. M. Posthuma, Josée M. Zijlstra, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed

Get full text

A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics by Johanna A. A. Bult, Francien Huisman, Yujie Zhong, Nick Veltmaat, Joost Kluiver, Sanne H. Tonino, Joost S. P. Vermaat, Martine E. D. Chamuleau, Arjan Diepstra, Anke van den Berg, Wouter J. Plattel, Mirian Brink, Marcel Nijland

Get full text

Survival disparities between children and adolescents and young adults for the major subtypes of non-Hodgkin lymphoma in the Netherlands: a large population-based study by Maya Schulpen, Auke Beishuizen, Martine E. D. Chamuleau, Avinash G. Dinmohamed, Friederike A. G. Meyer-Wentrup, H. Josef Vormoor, Lotte E. van der Wagen, Monique C. Minnema, Jan L. C. Loeffen, Henrike E. Karim-Kos

Get full text

Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018 by Müjde Durmaz, Otto Visser, Eduardus F. M. Posthuma, Rolf E. Brouwer, Djamila E. Issa, Daphne de Jong, King H. Lam, Nicole M. A. Blijlevens, Josée M. Zijlstra, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed

Get full text

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma by Pier Luigi Zinzani, Lionel Karlin, John Radford, Dolores Caballero, Paul Fields, Martine E. D. Chamuleau, Francesco d’Amore, Corinne Haioun, Catherine Thieblemont, Eva González-Barca, Carlos Grande García, Peter W. Johnson, Gustaaf W. van Imhoff, Thomas Ng, Karen Dwyer, Franck Morschhauser

Get full text

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment by Hilma J. van der Horst, A. Vera de Jonge, Ida H. Hiemstra, Anne T. Gelderloos, Daniella R. A. I. Berry, Nathalie J. Hijmering, Hendrik F. van Essen, Daphne de Jong, Martine E. D. Chamuleau, Sonja Zweegman, Esther C. W. Breij, Margaretha G. M. Roemer, Tuna Mutis

Get full text

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma by Diana Al-Sarayfi, Frederik O. Meeuwes, Müjde Durmaz, Djamila E. Issa, Rolf E. Brouwer, Aart Beeker, Anna van Rhenen, Pim G. N. J. Mutsaers, Lara H. Böhmer, Marjolein W. M. van der Poel, Liane te Boome, Tom van Meerten, Martine E. D. Chamuleau, Josée M. Zijlstra, Mirian Brink, Marcel Nijland

Get full text